A Multicenter RCT of "3+7" vs Venetoclax + CACAG in Newly Diagnosed Mid/High-Risk AML Patients | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Multicenter RCT of "3+7" vs Venetoclax + CACAG in Newly Diagnosed Mid/High-Risk AML Patients	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Recruiting	Phase 2	2026-05-08		NCT06928376

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
940 Hospital of the People's Liberation Army Joint Logistic Support Force	7
960th Hospital of Joint Logistics Support Force of People's Liberation Army of China	7
Chinese PLA General Hospital	238
First Affiliated Hospital of Harbin Medical University	64
Jining First People's Hospital	26
The General Hospital of Western Theater Command	26
Yantai Yuhuangding Hospital	32

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Chinese PLA General Hospital	Beijing	China	87